Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate

AAPS Journal

Volumn 9, Issue 3, 2007, Pages

  Patel, Ashok R ^a   Vavia, Pradeep R ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Fenofibrate; Pseudoternary phase diagrams; SMEDDS; Triton induced hyperlipidemia

Indexed keywords

FENOFIBRATE; LIPID; MACROGOL 400; PLACEBO; POLYSORBATE 80; TYLOXAPOL; ANTILIPEMIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG SYNTHESIS; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRECIPITATION; RAT; ANIMAL; BLOOD; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTILIPEMIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EMULSIONS; LIPIDS; MALE; PROCETOFEN; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 38849151208     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/aapsj0903041     Document Type: Article

References (27)

1. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000;11:S93-S98.
2. Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res. 1995;12:1561-1572.
3. Kim HJ, Yoon KA, Hahn M, Park ES, Chi SC. Preparation and in vitro evaluatian of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm. 2000;26:523-529.
4. Kang BK, Lee JS, Chona SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274:65-73.
5. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolysed. glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106:15-23.
6. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87-93.
7. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233-246.
8. Physician's Desk Reference 2000. 54th ed. Montvale, NJ: Medical Economics Company; 2000:476-477.
9. Kasim NA, Whitehouse M, Ramachandran C, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm. 2004;1:85-96.
10. Patel AR, Vavia PR. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macrocycl Chem. 2006;56:247-251.
11. Law D, Wang W, Schmitt E, Qiu Y, Krill SK, Fort JJ. Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci. 2003;92:505-515.
12. Curtet B, Teillaud E, Reginault P, inventors. Fournier Innovation et Synergie, assignee. Novel dosage form of fenofibrate. US patent 4 895 726. January 23, 1980.
13. Tricor. fenofibrate [package insert]. North Chicago, IL: Abbott Laboratories. 2002.
14. Khoo SM, Humberstone AJ, Porter CJ, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155-164.
15. Zlatkis A, Zak B, Boyle AJ. New method for direct determination of serum cholesterol. J Lab Clin Med. 1953;41:486-492.
16. Foster IB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem. 1973;19:338-340.
17. Groves MJ. The self-emulsifying action of mixed surfactants in oil. Acta Pharm Suec. 1976;13:361-372.
18. Schulman JH, Montagne JB. Formation of microemulsions by amino alkyl alcohols. Ann N Y Acad Sci. 1961;92:366-371.
19. Mei X, Etzler FM, Wang Z. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006;324:128-135.
20. Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm. 1998;161:75-86.
21. Constantinides PP, Scalart JP. Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides. Int J Pharm. 1997;158:57-68.
22. de Campo L, Yaghmur A, Gard N, Leser ME, Folmer B, Glatter O. Five-component food-grade microemulsions: structural characterization by SANS. J Colloid Interface Sci. 2004;274:251-267.
23. Szekeres E, Acosta E, Sabatini DA, Harwell JH. A two-state model for selective solubilization of benzene-limonene mixtures in sodium dihexyl sulfosuccinate microemulsions. Langmuir. 2004;20:6560-6569.
24. Nutting DF, Tso P. Hypolipidemic effects of intravenous pluronic L-81 in fasted rats treated with Triton WR-1339: possible inhibition of hepatic lipoprotein secretion. Horm Metab Res. 1989;21:113-115.
25. Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 1972;7:68-74.
26. Krishnamurthy A, Thapar GS. Effect of benzafibrate and nicotinic acid on Triton-induced hyperlipidemias in CFY rats. Indian J Med Res. 1991;94:395-398.
27. Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw Hill; 2006:957-958.